The People Behind Our Progress
Our co-creation engine is driven by a dedicated group of executives, directors, and advisors. Each shares the belief that a new approach to science can expand new possibilities in immunology innovation for people living with long-overlooked diseases.
Management Team
This team brings entrepreneurial science to life, guiding our operations and impact day to day.
Karen Massey
Chief Executive Officer, Executive Director of the Board of Directors
Karl Gubitz
Chief Financial Officer
Peter Ulrichts
Chief Scientific Officer
Malini Moorthy
General Counsel
Luc Truyen
Chief Medical Officer
Arjen Lemmen
Vice President of Corporate Development & Strategy
Andria Wilk
Global Head of Quality
Marc Schorpion
Global Head of Human Resources
Beth DelGiacco
Vice President of Corporate Affairs
Filip Borgions
Chief Technology Innovation Officer
Achim Plueckebaum
Global Head of Digital Technologies
Sandrine Piret‑Gerard
Chief Commercialization Officer
An Vandebosch
Head of Development
Our board safeguards the bold, unconventional path we’ve chosen to pursue.
Tim Van Hauwermeiren
Co-Founder, Non-Independent Non-Executive Director and Chairperson of the Board
Dr. Pamela M. Klein
Non-Executive Director
Tony Rosenberg
Non-Executive Director, Vice Chairperson of the Board
Camilla Sylvest
Non-Executive Director
Dr. Ana Cespedes
Non-Executive Director, Chairperson of the Remuneration & Nomination Committee
Steve Krognes
Non-Executive Director, Chairperson of the Audit & Compliance Committee, Member of the Remuneration & Nomination Committee
Dr. Brian Kotzin
Non-Executive Director and Chairperson of the R&D Committee
Thomas Brakel
Strategic Advisor to the R&D Committee
Khurem Farooq
Strategic Advisor to the R&D Committee
Karen Massey
Chief Executive Officer, Executive Director of the Board of Directors
Board Advisors
These advisors bring outside perspectives and scientific expertise to sharpen our thinking and strengthen our rigor.
David L. Lacey
Strategic Advisor to the R&D Committee
Hans de Haard
Co-Founder, Strategic Advisor to the R&D Committee
Wim Parys
Strategic Advisor to the R&D Committee
Mary Lynne Hedley
Strategic Advisor to the R&D Committee
Bart Lambrecht
Strategic Advisor to the R&D Committee
Explore More
At argenx, every piece of the innovation story connects. See where it leads next.
Grants
Funding research, education, and initiatives that raise the standard of care.
About Us
Discover why we’re more than a unique name.
Newsroom
The latest news and press releases from argenx.
